Lipocine Corp (LPCN): Price to Sales

Corporate company logo of Lipocine Corp (LPCN)

Lipocine Inc. relies on the Lip'ral IT system to automate drug delivery simulations, offering a convenient tablet-based alternative to injections via Oral-lyn. The brand's high authority among endocrinologists confirms the company's scientific foundation. The price-to-sales ratio visualizes the link between market value and sales, with the value fixed at 4.80, helping to distinguish speculation from the asset's fundamental value.

Lipocine - LPCN P/S Multiple (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Lipocine Corp (LPCN)

- current price and projected stock value:
Price Chart lipocine.com|LPCN - Price Target Chart
- stock exchange capitalization data:
Market Value Lipocine Corp|LPCN - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Lipocine|LPCN - Book Capitalization|Market Capitalization to Book Value lipocine.com|LPCN - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Lipocine Inc.|LPCN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Lipocine Corporation|LPCN - Company Debts|Debt to Book Capitalization Ratio Lipocine Corp|LPCN - Company Long-Term Debts|Short-Term Debt Volume Lipocine|Critical Liquidity Ratio lipocine.com
- financial results and valuation multiples details:
LPCN - Company Net Income|Expected Net Profit Lipocine Inc.|LPCN - P/E Multiple|Projected Price to Earnings Lipocine Inc|LPCN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Lipocine Corp|LPCN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Lipocine|LPCN - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months lipocine.com|LPCN - Net earnings per share growth this year|Expected earnings per share trend next year Lipocine Inc.
- issuer revenue and sales details:
LPCN - Revenue and Sales Volume|Company Future Sales lipocine.com|LPCN - Price-to-Revenue Ratio|Market Cap to Projected Revenue Lipocine Corp
Fundamental company analysis:lipocine.com LPCN
Core merchandise of Lipocine Inc.

The expansion of oral drugs from the Lip'ral platform determines the potential for commercial capture of the small molecule market. Analyzing the P/S ratio chart, an investor assesses the market value of Lipocine Inc. (LPCN) relative to its actual revenue. This metric measures the amount of capital the market is willing to pay per unit of generated revenue, revealing whether the asset is overvalued or undervalued. Low values confirm the business's resilience to shocks, provided that sales continue to grow.

Competing companies

Price-to-Revenue Ratio ASND (ascendispharma.com)|Price-to-Revenue Ratio Madrigal Pharmaceuticals, Inc. MDGL|Corcept Therapeutics Inc. (CORT) - Price to Sales|RYTM - Price-to-Revenue Ratio|AKRO: Price-to-Revenue Ratio|MTSR: P/S Multiple|MLTX - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Crinetics|NewAmsterdam Pharma Company (NAMS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Soleno (SLNO)|Market Cap to Revenue Amicus Corp FOLD|Price-to-Revenue Ratio 89bio, Inc. ETNB|agios.com - Price-to-Revenue Ratio|Structure Therapeutics Inc. - P/S Multiple|Price-to-Revenue Coefficient MiMedx Group Inc MDXG|Rezolute Corp (RZLT) - Price-to-Revenue Ratio|Price-to-Sales Ratio LXRX (Lexicon Corp)|Price-to-Revenue Ratio MBX Biosciences Inc|Price to Sales altimmune.com ALT|P/S Multiple AARD|Market Cap to Revenue Sagimet Biosciences, Inc. SGMT|P/S Multiple BIOA (BioAge Labs Inc.)|Price-to-Revenue Coefficient Biomea Fusion Corp (BMEA)|QNCX - Price-to-Revenue Ratio|GUTS (fractyl.com) - Market Cap to Revenue Ratio|VTVT: P/S Multiple|Price to Sales Agape ATP (ATPC)|Market Cap to Revenue PLUR|SYBX: Market Capitalization-to-Revenue Ratio|P/S Multiple MTNB|Price-to-Revenue Coefficient sprucebiosciences.com|Price-to-Revenue Ratio Galecto GLTO|CTCX: Market Cap to Revenue Ratio|Lumos Pharma Corp - P/S Multiple|Organovo Corp (ONVO) - Market Cap to Revenue|RDUS (Radius Recycling, Inc.) - Market Cap to Revenue